EcoDrugPlus

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSEEUG00000005127
Gene Symbol: AKR1B1
1 External references
426 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSEEUG00000005888
Gene Symbol: GAA
1 External references
233 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSEEUG00000007924
Gene Symbol: AOC1
1 External references
233 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSEEUG00000007755
Gene Symbol: APP
1 External references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSEEUG00000010162
Gene Symbol: AR
1 External references
277 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSEEUG00000012908
Gene Symbol: AGTR2
4 External references
195 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSEEUG00000012569
Gene Symbol: APEX1
1 External references
214 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSEEUG00000009685
Gene Symbol: ALOX12
1 External references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSEEUG00000006465
Gene Symbol: ALOX5
1 External references
223 Possible Orthologues:

Arachidonate 5-Lipoxygenase Activating Protein

Ensembl ID : ENSEEUG00000001046
Gene Symbol: ALOX5AP
1 External references
201 Possible Orthologues:

Arginine Vasopressin Receptor 1b

Ensembl ID : ENSEEUG00000000923
Gene Symbol: AVPR1B
1 External references
136 Possible Orthologues:

Aryl Hydrocarbon Receptor

Ensembl ID : ENSEEUG00000002330
Gene Symbol: AHR
1 External references
155 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).